Elsa Ohlen

Articles by Elsa Ohlen

Cholesterol drug setback casts doubt over multibillion-dollar race - cnbc.com

Business September 9, 2026

Blood sample for a lipoprotein(a) test. Novartis' failure in a closely watched cardiovascular trial has raised questions about one of the pharmaceutical industry's biggest drug races and rival treat�...

Novo Nordisk shares dive 9% after heart medicine fails trial - CNBC

Business August 1, 2026

Shares of Novo Nordisk fell as much as 10% on Friday after the drugmaker said a late-stage heart drug trial failed to reduce major adverse cardiovascular events, or MACE, compared to a placebo. Whil�...

'Bubble effect': Weight loss drug fueled growth is putting the pharma sector at risk, report finds - CNBC

Business May 5, 2026

Surging demand for weight loss and diabetes drugs leaves the pharmaceutical sector at risk from a "bubble effect" as profitability soars, new research suggests. Demand for the likes of Wegovy and Z�...

AstraZeneca stock falls after FDA panel votes against new cancer drug - CNBC

Business May 2, 2026

Shares of AstraZeneca turned lower Friday after U.S. regulatory advisors voted against approving its experimental cancer drug.  An advisory panel for the U.S. Food and Drug Administration late Thurs...

Spotify stock plummets after earnings beat expectations as guidance disappoints - CNBC

Business April 29, 2026

Shares of Swedish audio-streamer Spotify fell over 13% after the market opened Tuesday, as soft guidance overshadowed an earnings beat. The company said first-quarter revenue rose 8% from last year �...

Gucci-owner Kering jumps 12% as new CEO maps revival, sales beats estimates - CNBC

Business February 11, 2026

Customers shop at a GUCCI luxury store in Shanghai, China. Kering said it expects a return to growth this year even as it posted another quarter of sales declines on Tuesday, with its biggest sales �...

Novo Nordisk shares tumble after company warns of sales hit this year - CNBC

Business February 4, 2026

Novo Nordisk signage on the floor of the New York Stock Exchange in New York, US, on Friday, Jan. 2, 2026. Novo Nordisk's U.S. shares plummeted Tuesday after the company said it sees sales and profi�...